Literature DB >> 15811552

Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).

Naoki Suzuki1, Masashi Aoki, Yuji Hinuma, Toshiaki Takahashi, Yoshiaki Onodera, Aya Ishigaki, Masaaki Kato, Hitoshi Warita, Maki Tateyama, Yasuto Itoyama.   

Abstract

The SJL mouse is a model for human dysferlinopathy (limb-girdle muscular dystrophy type 2B and Miyoshi myopathy). We used cDNA microarrays to compare the expression profiles of 10,012 genes in control and SJL quadriceps femoris muscles in order to find genes involved in the degeneration and regeneration process and in dysferlin's functional network. Many genes involved in the process of muscle regeneration are observed to be up-regulated in SJL mice, including cardiac ankyrin repeated protein (CARP), Neuraminidase 2, interleukin-6, insulin-like growth factor-2 and osteopontin. We found the upregulation of S100 calcium binding proteins, neural precursor cell expressed, developmentally down-regulated gene 4-like (NEDD4L) with C2 domain, and intracellular protein traffic associated proteins (Rab6 and Rab2). These proteins have the potential to interact with dysferlin. We must reveal some other molecules which may work with dysferlin in order to clarify the pathological network of dysferlinopathy. This process may lead to future improvements in the therapy for human dysferlinopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811552     DOI: 10.1016/j.neures.2005.01.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  14 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

Review 2.  Sialidase significance for cancer progression.

Authors:  Taeko Miyagi; Kohta Takahashi; Keiko Hata; Kazuhiro Shiozaki; Kazunori Yamaguchi
Journal:  Glycoconj J       Date:  2012-05-29       Impact factor: 2.916

3.  Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.

Authors:  Renzhi Han; Ellie M Frett; Jennifer R Levy; Erik P Rader; John D Lueck; Dimple Bansal; Steven A Moore; Rainer Ng; Daniel Beltrán-Valero de Bernabé; John A Faulkner; Kevin P Campbell
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

Review 4.  Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology.

Authors:  Jin-Ming Tee; Maikel P Peppelenbosch
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

5.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

6.  Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice.

Authors:  Kinji Kobayashi; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2011-03-31       Impact factor: 1.628

Review 7.  Dysferlin at transverse tubules regulates Ca(2+) homeostasis in skeletal muscle.

Authors:  Jaclyn P Kerr; Christopher W Ward; Robert J Bloch
Journal:  Front Physiol       Date:  2014-03-06       Impact factor: 4.566

8.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

9.  Dysferlin and animal models for dysferlinopathy.

Authors:  Kinji Kobayashi; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2012-06       Impact factor: 1.628

10.  Muscle Gene Sets: a versatile methodological aid to functional genomics in the neuromuscular field.

Authors:  Apostolos Malatras; Stephanie Duguez; William Duddy
Journal:  Skelet Muscle       Date:  2019-05-03       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.